APOL1

2 papers

HGNC NCBI Gene Taxon

1 trial

Funder: National Institute of Diabetes and Digestive and Kidney Diseases
1 of 1 trial sponsored by developers of drugs on it

Cells1

Funding

1 grant since 2026

National Institute of Diabetes and Digestive and Kidney DiseasesUS$383.1k

Kidney tubule dysfunction in APOL1
National Institute of Diabetes and Digestive and Kidney DiseasesVeterans Medical Research Fdn/san DiegoUS$383.1k2026–2031

Latest

1 in 12 months

Zenodo7 Apr

p53 as a Convergent Genetic Modifier in Chronic Kidney Disease: Unifying the Secondary Risk Gene Landscape and Defining the Conceptual Basis for Renal Modulatory Drugs (RMDs)

Preprint: reviewTP53

bioRxiv29 Jul

Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine derived SIX2-positive renal progenitor cell line

Preprint: experiments in human cellsRenal fibrosis